Determining the pneumococcal conjugate vaccine coverage required for indirect protection within Asia and the Pacific: a prospective observational study

• Main Authors: Jocelyn Chan, MBBS (Author), Jana Y Lai, BScK (Author), Claire von Mollendorf, PhD (Author), Christopher Blyth, PhD (Author), David A B Dance, FRCPath (Author), Siddhartha Datta, MD (Author), Eileen M Dunne, PhD (Author), Rebecca Ford, PhD (Author), Kimberley Fox, MD (Author), Jason Hinds, PhD (Author), Keoudomphone Vilivong, MD (Author), Sophie La Vincente, PhD (Author), Deborah Lehmann, MBBS (Author), Kerryn A Moore, PhD (Author), Tuya Mungun, MD (Author), Monica L Nation, MEpi (Author), Paul N Newton, MRCP (Author), Cattram D Nguyen, PhD (Author), William Pomat, PhD (Author), Anonh Xeuatvongsa, PhD (Author), Catherine Satzke, PhD (Author), E Kim Mulholland, MD (Author), Fiona M Russell, PhD (Author)
• Format: Book
• Published: Elsevier, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pneumococcal disease is an important cause of childhood morbidity and mortality worldwide. Evidence is required to support the introduction of pneumococcal conjugate vaccines (PCVs) in low-income and middle-income countries (LMICs). PCVs prevent disease through both direct protection of...